Morita saw no growth in patent filings in April and highest growth of 2.49% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.66%. GlobalData’s DataBook provides a comprehensive analysis of Morita’s patent filings and grants. Buy the databook here.
Morita has been focused on protecting inventions in European Patent Office(EPO) with five publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 50% filings and 33% grants. The European Patent Office(EPO), United States(US), Germany(DE), and Austria(AT) patent Office are among the top ten patent offices where Morita is filings its patents. Among the top granted patent authorities, Morita has 44% of its grants in Germany(DE), 33% in European Patent Office(EPO) and 11% in United States(US).
3Shape Holding could be the strongest competitor for Morita
Patents related to healthtech and data analytics lead Morita's portfolio
Morita has the highest number of patents in healthtech followed by, data analytics and artificial intelligence. For healthtech, nearly 50% of patents were filed and 50% of patents were granted in Q2 2024.
Dental devices related patents lead Morita portfolio followed by diagnostic imaging, and general surgery devices
Morita has highest number of patents in dental devices followed by diagnostic imaging, general surgery devices, neurology devices, and ophthalmic devices. For dental devices, nearly 22% of patents were filed and 33% of patents were granted in Q2 2024.
For comprehensive analysis of Morita's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.